Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Sci Rep ; 13(1): 12491, 2023 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-37528129

RESUMEN

Animal venoms are rich sources of neuroactive compounds, including anti-inflammatory, antiepileptic, and antinociceptive molecules. Our study identified a protonectin peptide from the wasp Parachartergus fraternus' venom using mass spectrometry and cDNA library construction. Using this peptide as a template, we designed a new peptide, protonectin-F, which exhibited higher antinociceptive activity and less motor impairment compared to protonectin. In drug interaction experiments with naloxone and AM251, Protonectin-F's activity was decreased by opioid and cannabinoid antagonism, two critical antinociception pathways. Further experiments revealed that this effect is most likely not induced by direct action on receptors but by activation of the descending pain control pathway. We noted that protonectin-F induced less tolerance in mice after repeated administration than morphine. Protonectin-F was also able to decrease TNF-α production in vitro and modulate the inflammatory response, which can further contribute to its antinociceptive activity. These findings suggest that protonectin-F may be a potential molecule for developing drugs to treat pain disorders with fewer adverse effects. Our results reinforce the biotechnological importance of animal venom for developing new molecules of clinical interest.


Asunto(s)
Péptidos , Venenos de Avispas , Ratones , Animales , Venenos de Avispas/química , Péptidos/farmacología , Péptidos/uso terapéutico , Morfina/farmacología , Analgésicos Opioides , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Dolor/tratamiento farmacológico , Analgésicos/farmacología , Analgésicos/uso terapéutico
3.
JMIR Res Protoc ; 10(1): e24298, 2021 Jan 19.
Artículo en Inglés | MEDLINE | ID: mdl-33290246

RESUMEN

BACKGROUND: The COVID-19 pandemic has led to high levels of physical, psychological, and social stress among health care professionals, including postgraduate students in medical and multidisciplinary residencies. This stress is associated with the intense fear of occupational exposure to SARS-CoV-2, the virus known to cause COVID-19. These professionals are at risk of developing physical and mental illnesses not only due to the infection but also due to prolonged exposure to multidimensional stress and continued work overload. OBJECTIVE: This study aims to evaluate the prevalence of symptoms suggestive of mental disorders and burnout syndrome and determine the risk factors for burnout among postgraduate students in medical and multidisciplinary residencies in Brazil during the COVID-19 pandemic. METHODS: For this prospective cohort study with parallel groups, participants were recruited between July and September 2020 to achieve a sample size of at least 1144 participants. Research instruments such as Depression, Anxiety, and Stress Scale; Patient Health Questionnaire; Brief Resilient Coping Scale; and Oldenburg Burnout Inventory will be used to collect data. Data will be collected in 2 waves: the first wave will include data related to sample characterization and psychosocial evaluation, and the second wave will be launched 12 weeks later and will include an evaluation of the incidence of burnout as well as correlations with the potential predictive factors collected in the first wave. Additionally, we will collect data regarding participants' withdrawal from work. RESULTS: The recruitment took place from July 29 to September 5, 2020. Data analyses for this phase is already in progress. The second phase of the study is also in progress. The final data collection began on December 1, 2020, and it will be completed by December 31, 2020. CONCLUSIONS: We believe the findings of this study will help evaluate the impact of the COVID-19 pandemic on the mental health conditions of health professionals in Brazil as well as contribute to the planning and implementation of appropriate measures that can alleviate these mental health challenges. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/24298.

5.
Pulmäo RJ ; 24(2): 35-38, 2015.
Artículo en Portugués | LILACS | ID: lil-778801

RESUMEN

A hipertensão portopulmonar (POPH) é definida como hipertensão pulmonar na presença de hipertensão portal. Acomete cerca de 5% dos pacientes com hipertensão portal, cirróticos ou não, em avaliação para transplante hepático. A fisiopatologia dessa doença não está completamente elucidada. O hiperfluxo pulmonar e a formação conexões porto-sistêmicas, que permitem o acesso de bactérias e de substâncias inflamatórias aos pulmões, são mecanismos prováveis. Variações genéticas possivelmente estão implicadas na variabilidade do comprometimento vascular pulmonar dos pacientes com hipertensão portal. O ecocardiograma tem papel importante como rastreamento, sendo o diagnóstico definitivo realizado através do cateterismo cardíaco direito. A POPH pode ser considerada contraindicação ao transplante hepático, nos casos moderados e graves, no entanto, o tratamento com vasodilatadores pulmonares, indicado para esses pacientes, pode ser capaz de melhorar o perfil hemodinâmico e permitir que mais pacientes atinjam os critérios de segurança para o transplante. Com as novas abordagens terapêuticas, observou-se melhora no prognóstico desses pacientes nos últimos anos...


Portopulmonary hypertension (POPH) is defined as pulmonary hypertension in the presence of portal hypertension. It affects about 5% of patients with portal hypertension, cirrhotic or not, under evaluation for liver transplantation. The pathophysiology of this disease is not completely understood, but hyperdynamic state in pulmonary circulation and formation of porto-systemic connections, which allow access of intestinal bacteria and inflammatory substances to the lungs, are probably involved. Genetic variations possibly play a role in the variability of the pulmonary vascular impairment of patients with portal hypertension. Echocardiography is important for screening, but the definitive diagnosis is made by right heart catheterization. The POPH can be considered a contraindication for liver transplantation in moderate to severe cases, however, treatment with pulmonary vasodilators, indicated for these patients, may be able to improve hemodynamic profile and allow more patients meet the criteria for transplantation. With new therapeutic approaches, there was an improvement in the prognosis of these patients in recent years...


Asunto(s)
Humanos , Masculino , Femenino , Hipertensión Pulmonar , Hipertensión Portal/diagnóstico , Hipertensión Portal/epidemiología , Hipertensión Portal/fisiopatología , Hipertensión Portal/terapia , Trasplante de Hígado
6.
Respir Physiol Neurobiol ; 187(2): 157-63, 2013 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-23537586

RESUMEN

Inhaled nitric oxide (NO) causes selective pulmonary vasodilatation and may improve gas exchange. The study was aimed to evaluate the acute effects of inhaled NO on pulmonary gas exchange in severe unilateral pneumonia, where hypoxemia results from increased intrapulmonary shunt. We studied 8 patients without preexisting lung disease (59±18 yr; 4M/4F) with early unilateral severe pneumonia and respiratory failure. Pulmonary and systemic hemodynamics and gas exchange, including ventilation-perfusion (V;A/Q;) distributions, were measured at baseline and while breathing 5 and 40 parts per million (ppm) of NO. Inhaled NO caused a dose-dependent fall in pulmonary vascular resistance (by 12% and 21%, with 5 and 40ppm, respectively; p<0.01, each) and improvement of PaO2 (by 25% and 23%; p<0.05, each), owing to the reduction of intrapulmonary shunt (by 23% and 27%; p<0.05, each), without changes in the amount of perfusion to low V;A/Q; ratio alveolar units. Patients with greater baseline intrapulmonary shunt exhibited greater improvement in arterial oxygenation (r(2)=0.55, p<0.05). We conclude that low doses of inhaled NO improve pulmonary gas exchange in acute severe pneumonia.


Asunto(s)
Broncodilatadores/administración & dosificación , Óxido Nítrico/administración & dosificación , Neumonía/terapia , Administración por Inhalación , Anciano , Análisis de Varianza , Presión Sanguínea/efectos de los fármacos , Depsipéptidos/efectos de los fármacos , Femenino , Lateralidad Funcional , Hemodinámica/efectos de los fármacos , Humanos , Hiperemia/complicaciones , Hiperemia/terapia , Masculino , Persona de Mediana Edad , Neumonía/complicaciones , Neumonía/microbiología , Intercambio Gaseoso Pulmonar , Adulto Joven
7.
Respir Physiol Neurobiol ; 179(2-3): 326-33, 2011 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-22005255

RESUMEN

Intrapulmonary vasodilation is a hallmark of the hepatopulmonary syndrome (HPS). However, its effects on respiratory mechanical properties and lung morphology are unknown. To determine these effects, 28 rats were randomly divided to control and experimental HPS groups (eHPS). The spontaneous breathing pattern, gas exchange, respiratory system mechanical properties, and lung and liver morphology of the rats were evaluated. Tidal volume, minute ventilation and mean inspiratory flow were significantly reduced in the eHPS group. Chest wall pressure dissipation against the resistive and viscoelastic components and elastic elastance were increased in the eHPS group. The lung resistive pressure dissipation was lower but the viscoelastic pressure was higher in the eHPS group. The airway volume proportion of collagen and elastic fibers was increased in the eHPS animals (16% and 51.7%; P<0.05 and P<0.001, respectively). The proportion of collagen volume in the vasculature increased 29% in the eHPS animals (P<0.01). HPS presents with respiratory system mechanical disarray as well as airway and vascular remodeling.


Asunto(s)
Remodelación de las Vías Aéreas (Respiratorias)/fisiología , Síndrome Hepatopulmonar/fisiopatología , Mecánica Respiratoria/fisiología , Animales , Modelos Animales de Enfermedad , Síndrome Hepatopulmonar/patología , Hígado/patología , Hígado/fisiopatología , Masculino , Ratas , Ratas Wistar
8.
J Neurol ; 256(11): 1881-90, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19588081

RESUMEN

Pompe disease (glycogen storage disease type II or acid maltase deficiency) is an inherited autosomal recessive deficiency of acid alpha-glucosidase (GAA), with predominant manifestations of skeletal muscle weakness. A broad range of studies have been published focusing on Pompe patients from different countries, but none from Brazil. We investigated 41 patients with either infantile-onset (21 cases) or late-onset (20 cases) disease by muscle pathology, enzyme activity and GAA gene mutation screening. Molecular analyses identified 71 mutant alleles from the probands, nine of which are novel (five missense mutations c.136T > G, c.650C > T, c.1456G > C, c.1834C > T, and c.1905C > A, a splice-site mutation c.1195-2A > G, two deletions c.18_25del and c.2185delC, and one nonsense mutation c.643G > T). Interestingly, the c.1905C > A variant was detected in four unrelated patients and may represent a common Brazilian Pompe mutation. The c.2560C > T severe mutation was frequent in our population suggesting a high prevalence in Brazil. Also, eight out of the 21 infantile-onset patients have two truncating mutations predicted to abrogate protein expression. Of the ten late-onset patients who do not carry the common late-onset intronic mutation c.-32-13T > G, five (from three separate families) carry the recently described intronic mutation, c.-32-3C > A, and one sibpair carries the novel missense mutation c.1781G > C in combination with known severe mutation c.1941C > G. The association of these variants (c.1781G > C and c.-32-3C > A) with late-onset disease suggests that they allow for some residual activity in these patients. Our findings help to characterize Pompe disease in Brazil and support the need for additional studies to define the wide clinical and pathological spectrum observed in this disease.


Asunto(s)
Predisposición Genética a la Enfermedad , Enfermedad del Almacenamiento de Glucógeno Tipo II/diagnóstico , Enfermedad del Almacenamiento de Glucógeno Tipo II/genética , Mutación/genética , alfa-Glucosidasas/genética , Adolescente , Adulto , Edad de Inicio , Brasil/epidemiología , Brasil/etnología , Niño , Preescolar , Análisis Mutacional de ADN , Femenino , Frecuencia de los Genes , Genotipo , Enfermedad del Almacenamiento de Glucógeno Tipo II/epidemiología , Humanos , Lactante , Masculino , Persona de Mediana Edad
9.
Rev Port Pneumol ; 14(1): 159-64, 2008.
Artículo en Portugués | MEDLINE | ID: mdl-18265924

RESUMEN

We report the case of a 38 years-old female patient with Pompe disease, diagnosed eight years ago. Respiratory complaints appeared five years ago progressing to chronic respiratory failure. Nocturnal CPAP (continuous positive airway pressure) was prescribed last year, presenting progressive clinical worsening. She was referred to Hospital Universitário de Brasília, on account of respiratory failure and cor pulmonale. Thus, she began non-invasive ventilation (NIV) with bi-level positive airways pressure, and a polysomnography showed the need of spontaneous/timed mode associated with adjustments in breathing pressures to improve ventilation during sleep. There was significant clinical improvement after NIV support was established.


Asunto(s)
Presión de las Vías Aéreas Positiva Contínua , Enfermedad del Almacenamiento de Glucógeno Tipo II/complicaciones , Insuficiencia Respiratoria/etiología , Adulto , Femenino , Humanos , Enfermedad Cardiopulmonar/etiología , Insuficiencia Respiratoria/terapia
11.
J. pneumol ; 26(6): 291-296, nov.-dez. 2000. tab, graf
Artículo en Portugués | LILACS | ID: lil-339124

RESUMEN

O abandono do tratamento da tuberculose tem implicações sociais e epidemiológicas. Objetivos: Comparar características de pacientes que abandonaram o tratamento com os que não o abandonaram (controle), matriculados no CS-EPM/Unifesp, no período de 1995 a 1997, e verificar se os grupos educativos de sala de espera diminuíram a ocorrência dos abandonos. Método: Foi realizado estudo retrospectivo controlado com 100 pacientes (38 abandonos pareados para 62 controles) matriculados para tratamento de tuberculose, em que se verificaram as variáveis mais relacionadas ao abandono. Destes, 60 pacientes participaram voluntariamente de grupos educativos (16 abandonos e 44 controles). Resultados: As variáveis mais relacionadas ao abandono foram: sexo masculino, tabagismo, alcoolismo, uso de drogas, presença de fatores de risco para HIV e internação prévia. Os que participaram voluntariamente dos grupos educativos de sala de espera tinham características semelhantes ao total de pacientes estudados, mas houve menor ocorrência de abandono durante o tratamento (p < 0,05). Conclusão: Os autores concluem que, tendo-se amplamente disponíveis os meios para diagnóstico e seguimento dos pacientes com tuberculose, todos os esforços possíveis deverão estar concentrados para evitar o abandono, sobretudo nos pacientes de risco, que deverão ter à sua disposição grupos educativos sobre a doença


Asunto(s)
Humanos , Masculino , Femenino , Pacientes Desistentes del Tratamiento/estadística & datos numéricos , Educación en Salud , Tuberculosis Pulmonar/tratamiento farmacológico , Estudios de Casos y Controles , Distribución de Chi-Cuadrado , Oportunidad Relativa , Encuestas y Cuestionarios , Estudios Retrospectivos , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...